Application e-book: managing the risk of nitrosamines in medicinal drugs


Download this free e-book from Shimadzu to discover how you can quantify trace levels of nitrosamine impurities from various drug substances, drug products and solvents using ultra-fast mass spectrometry technologies.

The presence of potentially carcinogenic nitrosamines (NO+) in drug products must be monitored to avoid significant quantities building up during the manufacturing process.

It is believed that nitrosamines can be sourced from packaging, solvents/water, excipients and may even form during storage.

By utilising Shimadzu’s ultra-fast mass spectrometry technology with analytical intelligence, in either gas or liquid chromatography modes, industrial standards can easily be met to identify and quantify a range of nitrosamine drug impurities.

These rugged and sensitive systems can offer LOQ levels of approximately 2 ppb for some applications, with linearity assessed from as low as 0.1 ppb. In addition, analytical intelligence improves the efficiency of the entire workflow and maximises laboratory throughput.

Sign up for your free email newsletter

The e-book also contains sartan, metformin, residual solvent and other API analyses. Download your free copy today!

Featured Companies